메뉴 건너뛰기




Volumn 102, Issue 6, 2007, Pages 1333-1334

Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease [11]

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; MESALAZINE; PEGINTERFERON; PREDNISONE; RIBAVIRIN;

EID: 34249065208     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01131.x     Document Type: Letter
Times cited : (24)

References (5)
  • 1
    • 0035135319 scopus 로고    scopus 로고
    • Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection
    • Campbell S, Ghosh S. Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection. Eur J Gastroenterol Hepatol 2001 13 : 191 2.
    • (2001) Eur J Gastroenterol Hepatol , vol.13 , pp. 191-2
    • Campbell, S.1    Ghosh, S.2
  • 2
    • 0142218784 scopus 로고    scopus 로고
    • Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection.
    • Peterson JR, Hsu FC, Simkin PA, et al. Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis 2003 62 : 1078 82.
    • (2003) Ann Rheum Dis , vol.62 , pp. 1078-82
    • Peterson, J.R.1    Hsu, F.C.2    Simkin, P.A.3
  • 3
    • 4644370343 scopus 로고    scopus 로고
    • Biomedicines to reduce inflammation but not viral load in chronic HCV - What's the sense?
    • Chuang E, Del Vecchio A, Smolinski S, et al. Biomedicines to reduce inflammation but not viral load in chronic HCV - what's the sense? Trends Biotechnol 2004 22 : 517 23.
    • (2004) Trends Biotechnol , vol.22 , pp. 517-23
    • Chuang, E.1    Del Vecchio, A.2    Smolinski, S.3
  • 4
    • 13844294333 scopus 로고    scopus 로고
    • Etanercept Study Group. Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: A phase 2 randomized, double-blind, placebo-controlled study
    • Zein NN. Etanercept Study Group. Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: A phase 2 randomized, double-blind, placebo-controlled study. J Hepatol 2005 42 : 315 22.
    • (2005) J Hepatol , vol.42 , pp. 315-22
    • Zein, N.N.1
  • 5
    • 0038047689 scopus 로고    scopus 로고
    • Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease
    • Van den Brande JM, Braat H, Van den Brink GR, et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 2003 124 : 1774 85.
    • (2003) Gastroenterology , vol.124 , pp. 1774-85
    • Van Den Brande, J.M.1    Braat, H.2    Van Den Brink, G.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.